Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: An ecological study;Hospitalisations dues à la varicelle et l'herpès zoster avant et après la mise en œuvre de la vaccination monodose contre la varicelle en Australie: Une étude écologique

Bulletin of the World Health Organization

Volumn 92, Issue 8, 2014, Pages 593-604

  Heywood, Anita E ^a   Wang, Han ^b   Macartney, Kristine K ^b   McIntyre, Peter ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; AUSTRALIA; CHICKENPOX; CHILD; DATA ANALYSIS; DATA BASE; FUNDING; HERPES ZOSTER; HOSPITALIZATION; HUMAN; IMMUNIZATION; INCIDENCE; MORBIDITY; NATIONAL HOSPITAL MORBIDITY DATABASE; TREATMENT OUTCOME; ADOLESCENT; FEMALE; INFANT; MALE; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; STATISTICS AND NUMERICAL DATA;

HERPES ZOSTER;

ADOLESCENT; AUSTRALIA; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HERPES ZOSTER; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE;

EID: 84905260685     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.13.132142     Document Type: Article

References (45)

1. Gidding HF, MacIntyre CR, Burgess MA, Gilbert GL. The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiol Infect. 2003; 131(3): 1085-9. doi: http://dx. doi. org/10. 1017/S0950268803001134 PMID: 14959774.
2. WHO vaccine-preventable diseases: monitoring system. 2014 global summary [Internet]. Geneva: World Health Organization; 2014. Available from: http://apps. who. int/immunization_monitoring/globalsummary/schedules [cited 2013 Oct 24].
3. Marin M, Güris D, Chaves SS, Schmid S, Seward JF. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56(RR-4): 1-40.
4. Shah SS, Wood SM, Luan X, Ratner AJ. Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Pediatr Infect Dis J. 2010; 29(3): 199-204. doi: http://dx. doi. org/10. 1097/INF. 0b013e3181bbf2a0 PMID: 19949362.
5. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005; 352(5): 450-8. doi: http://dx. doi. org/10. 1056/NEJMoa042271 PMID: 15689583.
6. Wiese-Posselt M, Hellenbrand W. Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation. Euro Surveill. 2010; 15(16) PMID: 20429999.
7. SAGE Working Group on Varicella and Herpes Zoster Vaccines [Internet]. Geneva: World Health Organization; 2012. Available from: http://www. who. int/immunization/sage/sage_wg_varicella_zoster_may12/en/index. html [cited 2012 Dec 18].
8. National Health and Medical Research Council. Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. 10th ed. Canberra: Australian Government Department of Health; 2013.
9. Nolan TM. The Australian model of immunization advice and vaccine funding. Vaccine. 2010; 28 Suppl 1: A76-83. doi: http://dx. doi. org/10. 1016/j. vaccine. 2010. 02. 038 PMID: 20413003.
10. National Health and Medical Research Council. The Australian Immunisation Handbook. 9th ed. Canberra: Australian Government Department of Health; 2003.
11. Menzies R, Turnour C, Chiu C, McIntyre P. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Commun Dis Intell Q Rep. 2008; 32 Suppl: S2-67. PMID: 18711998.
12. Hull BP, Deeks SL, McIntyre PB. The Australian Childhood Immunisation Register-A model for universal immunisation registers? Vaccine. 2009; 27(37): 5054-60. doi: http://dx. doi. org/10. 1016/j. vaccine. 2009. 06. 056 PMID: 19576945.
13. 3201. 0 Population by age andsSex, Australian states and territories, June 2010 [Internet]. Canberra: Australian Bureau of Statistics; 2010. Available from http://www. abs. gov. au/AUSSTATS/abs@. nsf/Lookup/3201. 0Main+Features1Jun%202010?OpenDocument [cited 2014 May 2].
14. Ward K, Dey A, Hull B, Quinn HE, Macartney K, Menzies R. Evaluation of Australia's varicella vaccination program for children and adolescents. Vaccine. 2013; 31(10): 1413-9. doi: http://dx. doi. org/10. 1016/j. vaccine. 2012. 12. 052 PMID: 23290837.
15. Australian hospital statistics 2007-08. AIHW Cat. no. HSE 71. Canberra: Australian Institute of Health and Welfare; 2009.
16. 3238. 0 Experimental Estimates and Projections, Aboriginal and Torres Strait Islander Australians, 1991 to 2021. Canberra: Australian Bureau of Statistics; 2009. Available from: http://www. abs. gov. au/Ausstats/abs@. nsf/0/A03584675FA93CECCA25762A001D0701 [cited 2014 Mar 13].
17. Sengupta N, Booy R, Schmitt HJ, Peltola H, Van-Damme P, Schumacher RF, et al. Varicella vaccination in Europe: are we ready for a universal childhood programme? Eur J Pediatr. 2008; 167(1): 47-55. doi: http://dx. doi. org/10. 1007/s00431-007-0424-0 PMID: 17334784.
18. Joint Committee on Vaccination and Immunisation: Statement on varicella and herpes zoster vaccines. London: the National Archives; 2010. Available from: http://webarchive. nationalarchives. gov. uk/20130107105354/http:/www. dh. gov. uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_133599. pdf [cited 2014 Mar 13].
19. Carville KS, Riddell MA, Kelly HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine. 2010; 28(13): 2532-8. doi: http://dx. doi. org/10. 1016/j. vaccine. 2010. 01. 036 PMID: 20117265.
20. Marshall HS, McIntyre P, Richmond P, Buttery JP, Royle JA, Gold MS, et al. Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatr Infect Dis J. 2013; 32(5): 530-7. doi: http://dx. doi. org/10. 1097/INF. 0b013e31827e92b7 PMID: 23249914.
21. Lopez AS, Zhang J, Brown C, Bialek S. Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era. Pediatrics. 2011; 127(2): 238-45. doi: http://dx. doi. org/10. 1542/peds. 2010-0962 PMID: 21199857.
22. Chaves SS, Lopez AS, Watson TL, Civen R, Watson B, Mascola L, et al. Varicella in infants after implementation of the US varicella vaccination program. Pediatrics. 2011; 128(6): 1071-7. doi: http://dx. doi. org/10. 1542/peds. 2011-0017 PMID: 22123875.
23. Kwong JC, Tanuseputro P, Zagorski B, Moineddin R, Chan KJ. Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program? Vaccine. 2008; 26(47): 6006-12. doi: http://dx. doi. org/10. 1016/j. vaccine. 2008. 08. 016 PMID: 18761386.
24. Tan B, Bettinger J, McConnell A, Scheifele D, Halperin S, Vaudry W, et al. The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008. Pediatric Infectious Disease Journal 2012; 31(9): 956-63.
25. Pozza F, Piovesan C, Russo F, Bella A, Pezzotti P, Emberti Gialloreti L. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy. Vaccine. 2011; 29(51): 9480-7. doi: http://dx. doi. org/10. 1016/j. vaccine. 2011. 10. 022 PMID: 22015389.
26. Khandaker G, Marshall H, Peadon E, Zurynski Y, Burgner D, Buttery J, et al. Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Arch Dis Child. 2011; 96(5): 453-6. doi: http://dx. doi. org/10. 1136/adc. 2010. 206037 PMID: 21349886.
27. Reynolds MA, Watson BM, Plott-Adams KK, Jumaan AO, Galil K, Maupin TJ, et al. Epidemiology of varicella hospitalizations in the United States, 1995-2005. J Infect Dis. 2008; 197(s2) Suppl 2: S120-6. doi: http://dx. doi. org/10. 1086/522146 PMID: 18419384.
28. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA. 2005; 294(7): 797-802. doi: http://dx. doi. org/10. 1001/jama. 294. 7. 797 PMID: 16106004.
29. Scuffham PA, Lowin AV, Burgess MA. The cost-effectiveness of varicella vaccine programs for Australia. Vaccine. 1999; 18(5-6): 407-15. doi: http://dx. doi. org/10. 1016/S0264-410X(99)00261-3 PMID: 10519929.
30. Gidding HF, Brisson M, Macintyre CR, Burgess MA. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health. 2005; 29(6): 544-51. doi: http://dx. doi. org/10. 1111/j. 1467-842X. 2005. tb00248. x PMID: 16366065.
31. Gao Z, Gidding HF, Wood JG, MacIntyre CR. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiol Infect. 2010; 138(4): 457-68. doi: http://dx. doi. org/10. 1017/S0950268809990860 PMID: 19781116.
32. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000; 125(3): 651-69. doi: http://dx. doi. org/10. 1017/S0950268800004714 PMID: 11218215.
33. Jardine A, Conaty SJ, Vally H. Herpes zoster in Australia: evidence of increase in incidence in adults attributable to varicella immunization? Epidemiol Infect. 2011; 139(5): 658-65. doi: http://dx. doi. org/10. 1017/S0950268810001949 PMID: 20727248.
34. Patel MS, Gebremariam A, Davis MM. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol. 2008; 29(12): 1157-63. doi: http://dx. doi. org/10. 1086/591975 PMID: 18999945.
35. Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis. 2005; 191(12): 2002-7. doi: http://dx. doi. org/10. 1086/430325 PMID: 15897984.
36. Tanuseputro P, Zagorski B, Chan KJ, Kwong JC. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine. 2011; 29(47): 8580-4. doi: http://dx. doi. org/10. 1016/j. vaccine. 2011. 09. 024 PMID: 21939721.
37. Schmader K, Gnann JW Jr, Watson CP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008; 197(s2) Suppl 2: S207-15. doi: http://dx. doi. org/10. 1086/522152 PMID: 18419399.
38. Carapetis JR, Russell DM, Curtis N. The burden and cost of hospitalised varicella and zoster in Australian children. Vaccine. 2004; 23(6): 755-61. doi: http://dx. doi. org/10. 1016/j. vaccine. 2004. 07. 025 PMID: 15542199.
39. Jackson LA, Reynolds MA, Harpaz R. Hospitalizations to treat herpes zoster in older adults: causes and validated rates. Clin Infect Dis. 2008; 47(6): 754-9. doi: http://dx. doi. org/10. 1086/591132 PMID: 18680413.
40. Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001; 127(2): 305-14. doi: http://dx. doi. org/10. 1017/S0950268801005921 PMID: 11693508.
41. de Melker H, Berbers G, Hahné S, Rümke H, van den Hof S, de Wit A, et al. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006; 24(18): 3946-52. doi: http://dx. doi. org/10. 1016/j. vaccine. 2006. 02. 017 PMID: 16564115.
42. Public summary document for Measles, mumps, rubella and varicella vaccine, powder for injection vial with diluent syringe, 0. 5 mL, Priorix-Tetra©, November 2007 [Internet]. Canberra: Australian Government Department of Health; 2007. Available from: http://www. health. gov. au/internet/main/publishing. nsf/Content/pbac-psd-measles-nov07 [cited 2014 Mar 13].
43. Kattan JA, Sosa LE, Bohnwagner HD, Hadler JL. Impact of 2-dose vaccination on varicella epidemiology: Connecticut-2005-2008. J Infect Dis. 2011; 203(4): 509-12. doi: http://dx. doi. org/10. 1093/infdis/jiq081 PMID: 21199882.
44. Bialek SR, Perella D, Zhang J, Mascola L, Viner K, Jackson C, et al. Impact of a routine two-dose varicella vaccination program on varicella epidemiology. Pediatrics. 2013; 132(5): e1134-40. doi: http://dx. doi. org/10. 1542/peds. 2013-0863 PMID: 24101763.
45. Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Lancet. 2014; 383(9925): 1313-24. doi: http://dx. doi. org/10. 1016/S0140-6736(12)61461-5 PMID: 24485548.